Biomedical Engineering Reference
In-Depth Information
4. Lathrop, A.E., and Loeb, L. Further investigations on the origin of
tumors in mice. III. On the part played by internal secretion in the
spontaneous development of tumors.
J Cancer Res
1
, 1-19 (1916).
5. Lacassagne, A. The Relation Between Hormones and Cancer.
Can Med
, 112-117 (1937).
6. De Sombre, E.R., Puca, G.A., and Jensen, E.V. Purification of an estrophilic
protein from calf uterus.
Assoc J
37
Proc Natl Acad Sci U S A
64
, 148-154 (1969).
7. Cole, M.P., Jones, C.T., and Todd, I.D. A new anti-oestrogenic agent in
late breast cancer. An early clinical appraisal of ICI46474.
Br J Cancer
25
, 270-275 (1971).
8. Jordan, V.C. Tamoxifen: a most unlikely pioneering medicine.
Nat Rev
Drug Discov
2
, 205-213 (2003).
9. Bjornstrom, L., and Sjoberg, M. Mechanisms of estrogen receptor
signaling: convergence of genomic and nongenomic actions on target
genes.
, 833-842 (2005).
10. Lee, A.V., Cui, X., and Oesterreich, S. Cross-talk among estrogen receptor,
epidermal growth factor, and insulin-like growth factor signaling in
breast cancer.
Mol Endocrinol
19
Clin Cancer Res
7
, 4429s-4435s; discussion 4411s-
4412s (2001).
11. Schiff, R.,
Cross-talk between estrogen receptor and growth factor
pathways as a molecular target for overcoming endocrine resistance.
Clin Cancer Res
et al.
, 331S-336S (2004).
12. Arpino, G., Wiechmann, L., Osborne, C.K., and Schiff, R. Crosstalk
between the estrogen receptor and the HER tyrosine kinase receptor
family: molecular mechanism and clinical implications for endocrine
therapy resistance.
10
, 217-233 (2008).
13. McGuire, W.L. Estrogen receptors in human breast cancer.
Endocr Rev
29
J Clin Invest
, 73-77 (1973).
14. McGuire, W.L., Carbone, P.P. Sears, M.E.,
52
et al.
Estrogen receptors in
human breast cancer: An overview. in
Estrogen Receptors in Human
(eds. McGuire, W.L., Carbone, P.P. & Vollmer, E.P.) 1-8
(New York, NY, Raven Press, 1974).
15. Anderson, W.F., Chatterjee, N., Ershler, W.B., and Brawley, O.W. Estrogen
receptor breast cancer phenotypes in the Surveillance, Epidemiology,
and End Results database.
Breast Cancer
, 27-36 (2002).
16. Harvey, J.M., Clark, G.M., Osborne, C.K., and Allred, D.C. Estrogen
receptor status by immunohistochemistry is superior to the ligand-
binding assay for predicting response to adjuvant endocrine therapy
in breast cancer.
Breast Cancer Res Treat
76
J Clin Oncol
17
, 1474-1481 (1999).
